Back to Search
Start Over
Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer – Case Report
- Source :
- Clinical Lung Cancer. 23:e568-e572
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Pulmonary and Respiratory Medicine
Cancer Research
Oncology
Subjects
Details
- ISSN :
- 15257304
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Clinical Lung Cancer
- Accession number :
- edsair.doi...........61ce85335f39f47622baea3bbec77b7c
- Full Text :
- https://doi.org/10.1016/j.cllc.2022.08.010